MAPPYACTS enables precision medecine for children with therapeutic failure

Presented at the ASCO annual congress in Chicago in June 2019, the first results of MAPPYACTS, that we have cofunded giving 1.720.000€ thanks to the Children without Cancer races in 2017 and 2019, are promising : for 2/3 of the children whose tumor was analyzed, therapeutical targets could be identified, allowing them to benefit from targeted treatments in therapeutical trials like AcSé-ESMART.

Read the press release published in June 2019 by Gustave Roussy.